贝达药业跌2.03%，成交额1.65亿元，主力资金净流出596.14万元

Core Viewpoint - Benda Pharmaceutical's stock has experienced fluctuations, with a year-to-date increase of 26.74% but a recent decline of 5.31% over the past five trading days [1] Financial Performance - As of June 30, Benda Pharmaceutical reported a revenue of 1.731 billion yuan for the first half of 2025, representing a year-on-year growth of 15.37% [2] - The company's net profit attributable to shareholders was 140 million yuan, showing a significant decrease of 37.53% compared to the previous period [2] Stock Market Activity - On September 17, Benda Pharmaceutical's stock price was 68.10 yuan per share, with a trading volume of 165 million yuan and a turnover rate of 0.57% [1] - The total market capitalization of the company stood at 28.652 billion yuan [1] - The net outflow of main funds was 5.9614 million yuan, with large orders showing a buy of 38.5116 million yuan and a sell of 39.5442 million yuan [1] Shareholder Information - As of June 30, the number of shareholders increased to 32,100, a rise of 9.97% from the previous period [2] - The average number of circulating shares per shareholder decreased by 9.08% to 13,064 shares [2] - The top ten circulating shareholders included new entrants such as China Europe Medical Health Mixed A and South China CSI 500 ETF [3]